Back to search

Article

EPAS1 Adaptive Loss-of-Function Variants as Germline Determinants of Primary Antiangiogenic TKI Resistance in High-Altitude Hepatocellular Carcinoma: A Translational Pharmacogenomic Study

2026-08-07

Abstract excerpt

<h4>Purpose</h4> Host germline genetic variation as a determinant of tumor drug response remains underexplored. We evaluated whether EPAS1 (HIF-2α) adaptive loss-of-function variants, enriched in high-altitude-adapted populations, predispose HCC to primary antiangiogenic TKI resistance through a HIF-2α/STC2 signaling axis, with implications for TKI selection and belzutifan combination strategies. <h4>Experimental...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
47760776-7ac5-58ea-a877-dc81b8df596f
DOI
10.64898/2026.08.05.26358954
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EPAS1 Adaptive Loss-of-Function Variants as Germline Determinants of Primary Antiangiogenic TKI Resistance in High-Altitude Hepatocellular Carcinoma: A Translational Pharmacogenomic StudyDOI 10.64898/2026.08.05.26358954
Select a neighboring publication to make it the new centre.